Trial site
Eye Clinic Albury Wodonga
Albury, NSW 2640, AustraliaNot linked to an institution yet
- 7running trials
- 1closed trial
The trials here
What the 8 trials at this site are about, from their registry records.
- Phase
- Phase 23 trials
- Phase 33 trials
- Phase 1/21 trial
- Phase 41 trial
- Status
- Active, not recruiting5 trials
- Completed1 trial
- Not yet recruiting1 trial
- Recruiting1 trial
- Lead sponsor
- Kyowa Kirin Co., Ltd.2 trials
- 4D Molecular Therapeutics1 trial
- Annexon, Inc.1 trial
- Biojiva LLC1 trial
- McMaster University1 trial
- and 2 more
Running trials
Recruiting
A Phase 1/2 Study of the Safety and Efficacy of BRX011 Oral Administration Once Daily in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration
NCT07029945· Phase 1/2· Biojiva LLC· Source
Contact: Clinical Research Coordinator
Recruiting
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
NCT07064759· Phase 3· 4D Molecular Therapeutics· Source
Contact: 4DMT Patient Advocacy
Active, not recruiting
A Study to Evaluate the Efficacy and Safety of Orally Administered VX-01
NCT06770933· Phase 2· Vantage Biosciences Ltd· Source
Recruiting
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
NCT06541704· Phase 3· Regeneron Pharmaceuticals· Source
Contact: Clinical Trials Administrator
Active, not recruiting
A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of Vonaprument (Formerly ANX007) in Participants With Dry Age-Related Macular Degeneration (AMD) With Geographic Atrophy (GA)
NCT06510816· Phase 3· Annexon, Inc.· Source
Active, not recruiting
Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema
NCT06116916· Phase 2· Kyowa Kirin Co., Ltd.· Source
Active, not recruiting
Treat & Extend Versus Fixed Dosing With Faricimab for Management of Diabetic Macular Edema: A Pragmatic, Multi-center, Open-label, Randomized, Controlled Trial
NCT05610319· Phase 4· McMaster University· Source
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Report an error